We are live on ! Find out more
AMED

Amedisys
AMED

Delisted

AMED was delisted on the 14th of August, 2025.

Back to rankings

286 hedge funds and large institutions have $2.79B invested in Amedisys in 2023 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 90 increasing their positions, 115 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

450% more funds holding in top 10

Funds holding in top 10: 2 → 11 (+9)

2% more capital invested

Capital invested by funds: $2.74B → $2.79B (+$55.1M)

1.32% less ownership

Funds ownership: 91.96% → 90.64% (-1.3%)

5% less funds holding

Funds holding: 301 → 286 (-15)

22% less repeat investments, than reductions

Existing positions increased: 90 | Existing positions reduced: 115

26% less first-time investments, than exits

New positions opened: 39 | Existing positions closed: 53

93% less call options, than puts

Call options by funds: $5.97M | Put options by funds: $81.6M

Holders
286
Holders Change
-15
Holders Change %
-4.98%
% of All Funds
4.54%
Holding in Top 10
11
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+450%
% of All Funds
0.17%
New
39
Increased
90
Reduced
115
Closed
53
Calls
$5.97M
Puts
$81.6M
Net Calls
-$75.6M
Net Calls Change
-$69.6M

Top Buyers

1
PCM
Pentwater Capital Management
Florida
+$74.6M
2
PWAM
Park West Asset Management
California
+$60.8M
3
WCMNY
Westchester Capital Management (New York)
New York
+$57.3M
4
Millennium Management
Millennium Management
New York
+$55.9M
5
FCM
Farallon Capital Management
California
+$39.2M

Top Sellers

1
DM
Deerfield Management
New York
-$164M
2
RP
Riverbridge Partners
Minnesota
-$144M
3
JP Morgan Chase
JP Morgan Chase
New York
-$93.6M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$55.7M
5
Ameriprise
Ameriprise
Minnesota
-$38.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Qube Research & Technologies (QRT)
126
Qube Research & Technologies (QRT)
United Kingdom
$1.98M +$1.96M +21,233 New
MOACM
127
Mutual of America Capital Management
New York
$1.98M -$227K -2,455 -10%
AB
128
Amalgamated Bank
New York
$1.92M -$62.7K -679 -3%
Two Sigma Investments
129
Two Sigma Investments
New York
$1.9M -$2.23M -24,140 -54%
Group One Trading
130
Group One Trading
Illinois
$1.9M +$1.83M +19,763 +3,322%
LPL Financial
131
LPL Financial
California
$1.89M +$1.14M +12,292 +156%
MIM
132
MetLife Investment Management
New Jersey
$1.75M -$76.4K -827 -4%
AC
133
Athos Capital
Hong Kong
$1.68M +$741K +8,016 +80%
Allianz Asset Management
134
Allianz Asset Management
Germany
$1.51M – – –
OR
135
Olympiad Research
Connecticut
$1.49M +$719K +7,777 +95%
QCM
136
Quantinno Capital Management
New York
$1.49M +$58.2K +630 +4%
YCM
137
Yousif Capital Management
Michigan
$1.44M -$76.7K -830 -5%
D.E. Shaw & Co
138
D.E. Shaw & Co
New York
$1.44M -$17.6M -190,987 -93%
Nisa Investment Advisors
139
Nisa Investment Advisors
Missouri
$1.43M – – –
BCM
140
BCK Capital Management
Connecticut
$1.35M – – –
EPM
141
Equitec Proprietary Markets
Illinois
$1.34M +$1.32M +14,300 New
Treasurer of the State of North Carolina
142
Treasurer of the State of North Carolina
North Carolina
$1.31M +$6.47K +70 +0.5%
Skandinaviska Enskilda Banken (SEB)
143
Skandinaviska Enskilda Banken (SEB)
Sweden
$1.31M +$1.29M +14,000 New
Comerica Bank
144
Comerica Bank
Texas
$1.28M -$366K -3,963 -22%
EOJOAM
145
E. Ohman J:or Asset Management
Sweden
$1.26M -$240K -2,600 -16%
LIP
146
Lighthouse Investment Partners
Florida
$1.26M +$234K +2,537 +23%
SSG
147
Summit Securities Group
New York
$1.25M +$1.24M +13,400 New
State of Tennessee, Department of Treasury
148
State of Tennessee, Department of Treasury
Tennessee
$1.2M -$508K -5,500 -30%
SEI Investments
149
SEI Investments
Pennsylvania
$1.07M -$9.77M -105,691 -90%
TRSOTSOK
150
Teachers Retirement System of the State of Kentucky
Kentucky
$1.02M +$497K +5,375 +97%
4 5
6
7 8

AMED Hedge Fund Activity: Q3 2023 in Review

286 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q3 2023, worth a combined $2.79B — up 2% from $2.74B a quarter earlier.

Sellers outnumbered buyers: 53 funds closed out of AMED and 39 opened new positions — a net loss of 14 holders — while 115 trimmed existing stakes and 90 added.

The largest buyer was Pentwater Capital Management, adding an estimated $74.6M. The largest seller was Deerfield Management, exiting entirely with an estimated $164M sold.

  • 286 institutional investors held Amedisys (AMED) as of Q3 2023, down from 301 in Q2 2023.
  • Funds reported $2.79B of Amedisys stock for Q3 2023, up 2% quarter-over-quarter.
  • 39 funds opened new Amedisys positions in Q3 2023 and 53 closed out, a net change of -14 holders.
  • The largest Amedisys buyer in Q3 2023 was Pentwater Capital Management, an estimated $74.6M added.
  • The largest Amedisys seller in Q3 2023 was Deerfield Management, an estimated $164M sold.

Based on aggregated 13F filings for Q3 2023.